Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Torrent Pharmaceuticals Limited
  6. Financials
    500420   INE685A01028

TORRENT PHARMACEUTICALS LIMITED

(500420)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 330 355333 623430 029477 073--
Entreprise Value (EV)1 366 505387 633458 139500 543486 591470 585
P/E ratio 75,7x32,6x34,3x36,8x30,1x25,2x
Yield 0,87%0,86%1,38%0,89%0,99%1,30%
Capitalization / Revenue 4,31x4,20x5,37x5,47x4,89x4,37x
EV / Revenue 4,78x4,88x5,72x5,74x4,98x4,31x
EV / EBITDA 18,5x17,9x18,4x18,6x15,9x13,3x
Price to Book 6,99x6,92x7,40x7,21x6,17x5,34x
Nbr of stocks (in thousands) 169 222169 223169 223169 223--
Reference price (INR) 1 9521 9722 5412 8192 8192 819
Announcement Date 05/20/201905/26/202005/18/2021---
1 INR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 76 73079 39080 05087 17197 656109 086
EBITDA1 19 84021 70024 85026 91330 68935 454
Operating profit (EBIT)1 13 66015 16018 27020 14423 80927 590
Operating Margin 17,8%19,1%22,8%23,1%24,4%25,3%
Pre-Tax Profit (EBT)1 5 62011 87015 26018 82722 75227 595
Net income1 4 36010 25012 52012 92915 66818 746
Net margin 5,68%12,9%15,6%14,8%16,0%17,2%
EPS2 25,860,674,076,693,7112
Dividend per Share2 17,017,035,025,227,936,5
Announcement Date 05/20/201905/26/202005/18/2021---
1 INR in Million
2 INR
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales1 20 17019 95019 37021 68421 71821 837
EBITDA1 6 3506 0705 8206 8466 8146 716
Operating profit (EBIT)1 4 7004 4004 1705 1335 2915 095
Operating Margin 23,3%22,1%21,5%23,7%24,4%23,3%
Pre-Tax Profit (EBT)1 3 8403 5703 8304 2784 7604 546
Net income1 3 1002 9703 2403 5353 2853 205
Net margin 15,4%14,9%16,7%16,3%15,1%14,7%
EPS2 18,317,519,222,419,8-
Dividend per Share ------
Announcement Date 10/26/202002/08/202105/18/2021---
1 INR in Million
2 INR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 36 15054 01028 11023 4709 519-
Net Cash position1 -----6 488
Leverage (Debt / EBITDA) 1,82x2,49x1,13x0,87x0,31x-0,18x
Free Cash Flow1 11 3539 86016 76019 29219 48721 928
ROE (Net Profit / Equities) 15,4%21,5%23,5%20,9%22,1%22,7%
Shareholders' equity1 28 38547 74053 31061 82170 80182 473
ROA (Net Profit / Asset) 5,06%7,28%8,92%11,2%13,2%15,5%
Assets1 86 166140 795140 425115 785118 398120 945
Book Value Per Share2 279285343391457528
Cash Flow per Share2 10682,2119111119140
Capex1 6 6284 0603 3503 1213 5083 814
Capex / Sales 8,64%5,11%4,18%3,58%3,59%3,50%
Announcement Date 05/20/201905/26/202005/18/2021---
1 INR in Million
2 INR
Key data
Capitalization (INR) 477 072 692 224
Capitalization (USD) 6 360 350 156
Net sales (INR) 80 050 000 000
Net sales (USD) 1 069 708 150
Number of employees 13 505
Sales / Employee (INR) 5 927 434
Sales / Employee (USD) 79 208
Free-Float 28,6%
Free-Float capitalization (INR) 136 648 166 102
Free-Float capitalization (USD) 1 821 798 226
Avg. Exchange 20 sessions (INR) 32 694 262
Avg. Exchange 20 sessions (USD) 436 893
Average Daily Capital Traded 0,01%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA